# FEMLYV
> **NDA218718** · New Drug Application · Sponsor: MILLICENT PR · Approved 2024-07-22
## Drug
- **FDA Application Number:** NDA218718
- **Application type:** New Drug Application
- **Brand name:** FEMLYV
- **Generic name:** NORETHINDRONE ACETATE/ETHINYL ESTRADIOL
- **Active ingredients:** ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
- **Dosage form:** TABLET, ORALLY DISINTEGRATING
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MILLICENT PR
- **Manufacturer:** Millicent US, Inc.
- **First approval:** 2024-07-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218718)
---
*AI Analytics · CC0 1.0*